Malt1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Malt1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MALT1-IN-13 (compound 10m) is inhibitor for mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), which to binds MALT1 protease covalently and irreversibly, inhibits MALT1 with the IC50 of 1.7 μM. MALT1-IN-13 inhibits proliferation against ABC-DLBCL and induces apoptosis in ABC-DLBCL HBL1. MALT1-IN-13 regulates mTOR and PI3K-Akt pathways[1].

Malvidin 3,5-diglucoside chloride is a anthocyanin that can be isolated from Desmodium sandwicense[1].

MAMDC2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAMDC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAML1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAML1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAML2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAML2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAML3 Human Pre-designed siRNA Set A contains three designed siRNAs for MAML3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAMLD1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAMLD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAMSTR Human Pre-designed siRNA Set A contains three designed siRNAs for MAMSTR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN1A1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN1A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN1A2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN1A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN1B1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN1B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN1C1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN1C1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN2A1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN2A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN2A2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN2A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN2B1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN2B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN2B2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN2B2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAN2C1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAN2C1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MANBA Human Pre-designed siRNA Set A contains three designed siRNAs for MANBA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MANBAL Human Pre-designed siRNA Set A contains three designed siRNAs for MANBAL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MANEA Human Pre-designed siRNA Set A contains three designed siRNAs for MANEA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MANEAL Human Pre-designed siRNA Set A contains three designed siRNAs for MANEAL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MANF Human Pre-designed siRNA Set A contains three designed siRNAs for MANF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mannose 1-phosphate sodium is an endogenous metabolite. Mannose 1-phosphate sodium can be used to synthesize GDP-Man by the enzyme GDP-mannose pyrophosphorylase[1].

Mannose triflate is a glucose analog. Mannose triflate is a well-known precursor for 18F-FDG synthesis for PET applications. 18F-FDG is an imaging technique of cancer[1].

Mannose triflate is a glucose analog. Mannose triflate is a well-known precursor for 18F-FDG synthesis for PET applications. 18F-FDG is an imaging technique of cancer[1].

MANS peptide is an inhibitor for myristoylated alanine-rich C kinase substrate (MARCKS), which competes with MARCKS in cells for membrane binding, and thus inhibits the stimulation of mucin secretion and tumor metastasis[1].

MANS peptide TFA is the TFA salt form of MANS peptide (HY-P10218). MANS peptide TFA is an inhibitor for myristoylated alanine-rich C kinase substrate (MARCKS), which competes with MARCKS in cells for membrane binding, and thus inhibits the stimulation of mucin secretion and tumor metastasis[1].

MANS peptide TFA is the TFA salt form of MANS peptide (HY-P10218). MANS peptide TFA is an inhibitor for myristoylated alanine-rich C kinase substrate (MARCKS), which competes with MARCKS in cells for membrane binding, and thus inhibits the stimulation of mucin secretion and tumor metastasis[1].

MANS peptide TFA is the TFA salt form of MANS peptide (HY-P10218). MANS peptide TFA is an inhibitor for myristoylated alanine-rich C kinase substrate (MARCKS), which competes with MARCKS in cells for membrane binding, and thus inhibits the stimulation of mucin secretion and tumor metastasis[1].

MANSC1 Human Pre-designed siRNA Set A contains three designed siRNAs for MANSC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAO-A inhibitor 2 (compound HT4) is a monoamine oxidase A (MAO-A) inhibitor with an IC50 of 14.3 µM. MAO-A inhibitor 2 shows a less effect on MAO-B (IC50 of 106 µM) and shows almost ineffective on xanthine oxidase (XO). MAO-A inhibitor 2 can be used for the neurodegenerative disorders and oxidative stress research[1].

MAO-B-IN-30 (compound IS7) is a potent, selective and cross the blood-brain barrier MAO-B inhibitor with IC50 values of 19.176, 0.082 µM for MAO-A and MAO-B, respectively. MAO-B-IN-30 shows antiproliferative activity and non-cytotoxic. MAO-B-IN-30 reduces TNF-alpha, IL-6, NF-kB levels. MAO-B-IN-30 has the potential for the research of Parkinson’s disease[1].

MAO-B-IN-31 (Compound 30) is an effective and selective inhibitor of monoamine oxidase B (monoamine oxidase B). The IC50 value is 41 nM. MAO-B-IN-31 also inhibits α-syn and tau aggregation. MAO-B-IN-31 has neuroprotective activity[1].

MAO-B-IN-32 is an inhibitor of MAO-B (IC50 = 16 nM).MAO-B-IN-32 increases dopamine concentration in the brain by inhibiting MAO-B activity[1].

MAO-IN-4 (Compound 2l) is a monoamine oxidase (MAO) inhibitor, with IC50 values of 0.07 and 0.75 μM for MAO-A and MAO-B Enzymes, respectively. MAO-IN-4 can be used for the research of depression and Parkinson’s disease (PD)[1].

MAO-IN-5 (Compound ZINC000016952895) is a monoamine oxidase (MAO) inhibitor. According to the prediction of Swiss ADME, MAO-IN-5 can inhibit the CYP enzyme family, has blood-brain barrier (BBB) permeability, and has a high gastrointestinal absorption rate. MAO-IN-5 can be used in the study of neurological diseases[1].

MAOA Human Pre-designed siRNA Set A contains three designed siRNAs for MAOA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Maoa Mouse Pre-designed siRNA Set A contains three designed siRNAs for Maoa gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Maoa Rat Pre-designed siRNA Set A contains three designed siRNAs for Maoa gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAOB Human Pre-designed siRNA Set A contains three designed siRNAs for MAOB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Maob Mouse Pre-designed siRNA Set A contains three designed siRNAs for Maob gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Maob Rat Pre-designed siRNA Set A contains three designed siRNAs for Maob gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAP10 Human Pre-designed siRNA Set A contains three designed siRNAs for MAP10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAP1A Human Pre-designed siRNA Set A contains three designed siRNAs for MAP1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAP1B Human Pre-designed siRNA Set A contains three designed siRNAs for MAP1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAP1LC3A Human Pre-designed siRNA Set A contains three designed siRNAs for MAP1LC3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAP1LC3B Human Pre-designed siRNA Set A contains three designed siRNAs for MAP1LC3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.